BrainStorm levels up, bringing on former FDA leader Peter Pitts for new ALS bid

For Peter Pitts, a former associate commissioner at the FDA, the appointment to the board of BrainStorm Cell Therapeutics is an opportunity to fulfill a promise he made long ago to a patient with ALS.